Sarepta Therapeutics Inc (NASDAQ:SRPT)

64.00
Delayed Data
As of Feb 16
 +0.86 / +1.36%
Today’s Change
26.96
Today|||52-Week Range
68.90
+15.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues14.2M9.8M1.3M5.4M
 
 
 
 
 
Cost of Goods Sold------130.0K
 
 
Depreciation And Amortization1.3M3.7M5.2M5.6M
 
 
 
 
 
 
Operating ExpensesGross Income-------320.0K
 
 
General Expenses101.9M139.7M207.0M261.8M
 
 
 
 
 
Research And Development71.7M94.1M146.4M186.3M
 
 
 
 
 
Total Operating Expenses103.2M143.4M212.3M267.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-89.0M-133.7M-211.0M-262.2M
 
 
 
 
 
Extraordinary Charge-23.3M-2.8M-9.2M-4.6M
 
 
 
 
 
Interest Expense On Debt------535.0K
 
 
Other Expenses200.0K679.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-112.0M-135.8M-220.0M-267.3M
 
 
 
 
 
Net Income-112.0M-135.8M-220.0M-267.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.9M40.0M42.3M48.7M
 
 
 
 
 
Shares To Calculate EPS Diluted33.9M40.0M42.3M48.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.31-$3.39-$5.20-$5.49
 
 
 
 
 
EPS Diluted-$3.31-$3.39-$5.20-$5.49